Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New heart device aims to cut stroke risk in AFib patients
Disease control TerminatedThis study tests a new device (Laminar LAAC) to close off a part of the heart called the left atrial appendage in people with non-valvular atrial fibrillation. The goal is to reduce the risk of stroke and blood clots. About 1500 participants will be enrolled and compared to those…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 17, 2026 14:00 UTC
-
New device could help AFib patients ditch blood thinners
Disease control OngoingThis study tests a device that closes off a small pouch in the heart (the left atrial appendage) in people with atrial fibrillation who cannot take blood thinners. The goal is to reduce the risk of stroke without needing long-term medication. About 58 participants will be followe…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New catheter shows promise in controlling AFib episodes
Disease control OngoingThis study looks at how well a special catheter (THERMOCOOL SMARTTOUCH SF) works to treat a type of irregular heartbeat called paroxysmal atrial fibrillation. Researchers will track 150 people for one year to see if the procedure keeps their heart rhythm normal and is safe. The g…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC